Use of low dose naltrexone and change in use of prescription drugs in patients with inflammatory bowel disease... (Abstract)

The LDN Conference 2021: 4th - 6th June 2021

Up to 29 CME Credits Available + Sponsor, Exhibitor and Advertiser Opportunities.  [More Details]

Use of low dose naltrexone and change in use of prescription drugs in patients with inflammatory bowel disease – A drug utilization cohort study based on the Norwegian prescription register

Research in Social and Administrative Pharmacy
May–June 2017
https://www.sciencedirect.com/science/article/abs/pii/S1551741117302152

LDN is used increasingly for multiple autoimmune diseases including inflammatory bowel diseases. This study looked a prescriptions dispensed with LDN in 2013 in Norway and concluded there was benefit, but further studies are recommended.